Low-grade serous carcinoma: molecular features and contemporary treatment strategies
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Low-grade serous carcinoma: molecular features and contemporary treatment strategies
Authors
Keywords
-
Journal
Expert Review of Anticancer Therapy
Volume 15, Issue 8, Pages 893-899
Publisher
Informa UK Limited
Online
2015-06-04
DOI
10.1586/14737140.2015.1052411
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The role of secondary cytoreduction in low-grade serous ovarian cancer or peritoneal cancer
- (2015) Erin K. Crane et al. GYNECOLOGIC ONCOLOGY
- Updates and emerging therapies for rare epithelial ovarian cancers: One size no longer fits all
- (2015) Reinou S. Groen et al. GYNECOLOGIC ONCOLOGY
- Bevacizumab Shows Activity in Patients With Low-Grade Serous Ovarian and Primary Peritoneal Cancer
- (2014) Rachel N. Grisham et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Gynecologic Cancer InterGroup (GCIG) Consensus Review for Ovarian and Primary Peritoneal Low-Grade Serous Carcinomas
- (2014) Charlie Gourley et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Low-grade serous carcinoma: New concepts and emerging therapies
- (2013) Ignacio Romero et al. GYNECOLOGIC ONCOLOGY
- Survival in Women With Grade 1 Serous Ovarian Carcinoma
- (2013) Amanda Nickles Fader et al. OBSTETRICS AND GYNECOLOGY
- Hormonal therapy for recurrent low-grade serous carcinoma of the ovary or peritoneum
- (2012) David M. Gershenson et al. GYNECOLOGIC ONCOLOGY
- Ovarian low-grade serous carcinoma: A comprehensive update
- (2012) Ivan Diaz-Padilla et al. GYNECOLOGIC ONCOLOGY
- Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study
- (2012) John Farley et al. LANCET ONCOLOGY
- Reclassification of serous ovarian carcinoma by a 2-tier system
- (2011) Diane C. Bodurka et al. CANCER
- The Hormonal Receptor Status in Breast Cancer can be Altered by Neoadjuvant Chemotherapy: A Meta-Analysis
- (2011) Ning Zhang et al. CANCER INVESTIGATION
- The insulin-like growth factor 1 pathway is a potential therapeutic target for low-grade serous ovarian carcinoma
- (2011) Erin R. King et al. GYNECOLOGIC ONCOLOGY
- Tubal origin of ‘ovarian’ low-grade serous carcinoma
- (2011) Jie Li et al. MODERN PATHOLOGY
- The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory
- (2010) Robert J. Kurman et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Transcriptional Pathway Signatures Predict MEK Addiction and Response to Selumetinib (AZD6244)
- (2010) J. R. Dry et al. CANCER RESEARCH
- Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant
- (2009) David M. Gershenson et al. GYNECOLOGIC ONCOLOGY
- Genomic analysis of epithelial ovarian cancer
- (2008) John Farley et al. CELL RESEARCH
- Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum
- (2008) Kathleen M. Schmeler et al. GYNECOLOGIC ONCOLOGY
- New Insights Into the Pathogenesis of Serous Ovarian Cancer and Its Clinical Impact
- (2008) Keren Levanon et al. JOURNAL OF CLINICAL ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now